AVLS 2024 Symposium: Varithena's Impact through New Data and Case Experiences

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

AVLS 2024 Symposium: Varithena's Impact through New Data and Case Experiences

By Boston Scientific FEATURING Lowell Kabnick, Vinay Satwah

337 views

February 3, 2025

Hear Drs. Lowell Kabnick and Vinay Satwah's in-depth discussion of the newest Varithena data, accompanied by case presentations, and discover why Varithena is regarded as the optimal treatment choice by our faculty.

Comments 0

Varithena’s versatility and highlights from the Network Meta-Analysis

Feat. K. Sterling, L. Kabnick